Washington Research Foundation. appeared to be the VC, which was created in 1981. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Seattle.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Washington Research Foundation., startups are often financed by Madrona Venture Group, Ignition Partners, Alliance of Angels. The meaningful sponsors for the fund in investment in the same round are ARCH Venture Partners, W Fund, Summit Capital. In the next rounds fund is usually obtained by Madrona Venture Group, Ignition Partners, OpenView Venture Partners.
The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2016. Opposing the other organizations, this Washington Research Foundation. works on 7 percentage points less the average amount of lead investments. Speaking about the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2007. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 investment rounds annually.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Hyperion Therapeutics, VLST Corporation, Uptake Medical. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Pharmaceutical, Biopharma.
We also calculated 4 valuable employees in our database.
Related Funds
Funds with similar focus
Fund Name | Location |
Adler Chomsky & Warsawasky | Israel, Tel Aviv, Tel Aviv District |
Alpha Edison | California, Los Angeles, United States |
Drayton Park Capital | Pennsylvania, Radnor, United States |
Grupo ItNet | Barcelona, Catalonia, Spain |
Gutbrain Ventures | Boston, Massachusetts, United States |
HypoVereinsbank | Bayern, Germany, München |
Manifold Partners | Francisco, North Carolina, United States |
MT Partners | Japan, Tokyo |
P3 Technology Partners | - |
Palisades Growth Capital | California, Los Angeles, United States |
Power Generations, Inc. | Florida, Pompano Beach, United States |
Reliance Ports and Terminals | Gujarat, India, Jamnagar |
Soleus Capital | Connecticut, Greenwich, United States |
South Valley Angels | California, Morgan Hill, United States |
Startup Loft | Beijing, Beijing, China |
Tianjin Wanrong Wenfu Zichan Guanli Zhongxin (Youxian Hehuo) | China, Guangdong, Tianjin |
Tracxn Syndicate | Bangalore, India, Karnataka |
WCB EIT+ | Dolnoslaskie, Poland, Wroclaw |
Yihui Touzi | China, Guangdong, Shenzhen |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Monod Bio | $25M | 15 Aug 2022 | Seattle, Washington, United States | ||
SEngine Precision Medicine | $10M | 28 Jul 2022 | Seattle, Washington, United States | ||
Cyrus Biotechnology | $18M | 06 Dec 2021 | Seattle, Washington, United States | ||
Outpace Bio | $30M | 31 Mar 2021 | Seattle, Washington, United States | ||
MDmetrix | $1M | 25 May 2020 | Seattle, Washington, United States | ||
$200K | 04 May 2020 | Spokane, Washington, United States | |||
A-Alpha Bio | $2M | 24 Sep 2019 | Seattle, Washington, United States | ||
MDmetrix | $3M | 14 May 2019 | Seattle, Washington, United States | ||
AbSci | $12M | 30 May 2018 | Vancouver, Washington, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Monod Bio | $25M | 15 Aug 2022 | Seattle, Washington, United States | ||
SEngine Precision Medicine | $10M | 28 Jul 2022 | Seattle, Washington, United States | ||
Cyrus Biotechnology | $18M | 06 Dec 2021 | Seattle, Washington, United States | ||
Outpace Bio | $30M | 31 Mar 2021 | Seattle, Washington, United States | ||
MDmetrix | $1M | 25 May 2020 | Seattle, Washington, United States | ||
$200K | 04 May 2020 | Spokane, Washington, United States | |||
A-Alpha Bio | $2M | 24 Sep 2019 | Seattle, Washington, United States | ||
MDmetrix | $3M | 14 May 2019 | Seattle, Washington, United States | ||
AbSci | $12M | 30 May 2018 | Vancouver, Washington, United States |